| For: | Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Akkoc T, Küçükçakır N, Bozkurt M, Karaöz E. Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury. World J Crit Care Med 2025; 14(4): 103782 [PMID: 41377533 DOI: 10.5492/wjccm.v14.i4.103782] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315x/full/v14/i4/103782.htm |
| Number | Citing Articles |
| 1 |
Anastassiya Ganina, Naizabek Yerzhigit, Oleg Lookin, Aliya Orassay, Galiya Shaimardanova, Elmira Chuvakova, Manarbek Askarov, Abay Baigenzhin. Stem Cells in Post-Stroke Regenerative Therapy: Current Role of Wharton’s Jelly Mesenchymal Stem Cells in the Orchestrum. Brain Sciences 2026; 16(8) doi: 10.3390/brainsci16080775
|
| 2 |
Na Liu, Xue Zhao, Xicai Sun, Yongmei Liu, Jing Xu, Donghua Xu, Wenchang Sun. Mesenchymal stem cells-derived extracellular vesicles as a novel drug delivery carrier: engineering strategies and clinical safety estimation. Frontiers in Molecular Biosciences 2026; 13 doi: 10.3389/fmolb.2026.1838554
|
| 3 |
Shen Yang, Siliang Ge, Zhongyang Liu, Junyu Chen, Feifan Chang, Junmin Shen, Fanfeng Wu, Xinyu Sun, Zhongqi Wang, Yi Li, Mingming Zhang, Ruijing Chen, Taojin Feng, Tao Yin, Pincong Fu, Ming Chen, Pengbin Yin, Libo Hao. Exosome-enabled bone defect repair: mechanistic foundations, bioengineered delivery, and artificial intelligence-driven translation. Journal of Nanobiotechnology 2026; 24(1) doi: 10.1186/s12951-026-04176-w
|
| 4 |
Meiqi Chen, Chenyang Gu, Yishen Lai, Yuqi Lin, Yifan Xu, Xiaoyin Li, Xuyi Chen. Exosome-Based Diagnostics and Cell-Free Therapeutics for Traumatic Brain Injury: From Mechanisms to Bedside. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S580440
|
| 5 |
Haitao Zhang, Maoxiang Xu, Boyu Cai, Zhao Wang, Tianlong Li, Stephanie Jung, Fei Tan. Stem cell-derived exosome therapy for traumatic brain injury and its auditory complications. Biomedicine & Pharmacotherapy 2026; 201 doi: 10.1016/j.biopha.2026.119755
|
| 6 |
Ye Xiong, Yanlu Zhang, Zheng Gang Zhang, Michael Chopp. Mesenchymal stromal/stem cell-derived extracellular vesicles as a cell-free therapeutic strategy for traumatic brain injury. Brain Medicine 2026; doi: 10.61373/bm026i.0048
|